Table 5. Evaluation of four feature selection methods for defining a condensed biomarker signature for classification of two groups, using a 3-fold cross validation scheme repeated twice.
Method | Sample cohort 2 | Sample cohort 3 | ||||||
---|---|---|---|---|---|---|---|---|
Biomarker overlap | Biomarker overlap | |||||||
BE-SVM | SVMc | RF | BE-SVM | SVMc | RF | |||
ROC AUC | ROC AUC | |||||||
p-value | 90.1 (2.3) | 3 | 4 | 15 | 90.6 (1.3) | 8 | 7 | 20 |
BE-SVM | 95.9 (3.2) | 17 | 6 | 93.5 (1.1) | 15 | 9 | ||
SVMc | 96.7 (2.1) | 7 | 92.1 (0.5) | 9 | ||||
RF (SVM) | 94.5 (1.3) | 91.7 (0.8) | ||||||
RF (RF) | 95.1 (2.1) | 90.9 (0.8) |